Vinkers; Hendrik Maarten
Patent Applications and Registrations
Patent applications and USPTO patent grants for Vinkers; Hendrik Maarten.The latest application filed is for "hiv replication inhibiting pyrimidines".
- Vinkers; Hendrik Maarten - Antwerp BE
- Vinkers; Hendrik Maarten - Antwerpen BE
- Vinkers; Hendrik Maarten - City Antwerpen BE
- Vinkers, Hendrik Maarten - Beerse BE
| Patent | Date |
|---|---|
| HIV replication inhibiting pyrimidines Grant 10,611,732 - Guillemont , et al. | 2020-04-07 |
| Hiv Replication Inhibiting Pyrimidines App 20190322628 - Guillemont; Jerome Emile Georges ; et al. | 2019-10-24 |
| HIV replication inhibiting pyrimidines Grant 10,370,340 - Guillemont , et al. | 2019-08-06 |
| Hiv Replication Inhibiting Pyrimidines App 20180244632 - Guillemont; Jerome Emile Georges ; et al. | 2018-08-30 |
| HIV replication inhibiting pyrimidines Grant 9,981,919 - Guillemont , et al. May 29, 2 | 2018-05-29 |
| Hiv Replication Inhibiting Pyrimidines App 20170320835 - Guillemont; Jerome Emile Georges ; et al. | 2017-11-09 |
| Hiv Replication Inhibiting Pyrimidines App 20170121292 - Guillemont; Jerome Emile Georges ; et al. | 2017-05-04 |
| HIV replication inhibiting pyrimidines Grant 9,580,392 - Guillemont , et al. February 28, 2 | 2017-02-28 |
| HIV Replication Inhibiting Pyrimidines App 20140343006 - Guillemont; Jerome Emile Georges ; et al. | 2014-11-20 |
| Pyrimidine derivatives for the prevention of HIV infection Grant 8,828,982 - Heeres , et al. September 9, 2 | 2014-09-09 |
| Hiv Inhibiting Pyrimidines Derivatives App 20120076835 - Guillemont; Jerome Emile Georges ; et al. | 2012-03-29 |
| HIV inhibiting pyrimidines derivatives Grant 8,080,551 - Guillemont , et al. December 20, 2 | 2011-12-20 |
| HIV replication inhibiting purine derivatives Grant 8,026,245 - Janssen , et al. September 27, 2 | 2011-09-27 |
| HIV inhibiting 1,2,4-triazin-6-one derivatives Grant 7,923,554 - Hoornaert , et al. April 12, 2 | 2011-04-12 |
| Pyrimidine Derivatives For The Prevention Of Hiv Infection App 20100034810 - HEERES; Jan ; et al. | 2010-02-11 |
| HIV replication inhibiting pyrimidines and triazines Grant 7,585,870 - Guillemont , et al. September 8, 2 | 2009-09-08 |
| HIV inhibiting 1,2,4-triazines Grant 7,585,861 - Lewi , et al. September 8, 2 | 2009-09-08 |
| Heteroaryl amines as glycogen synthase kinase 3.beta. inhibitors (GSK3 inhibitors) Grant 7,514,445 - Freyne , et al. April 7, 2 | 2009-04-07 |
| Hiv Inhibiting 1,2,4-Triazin-6-One Derivatives App 20090012092 - Hoornaert; Georges Joseph Cornelius ; et al. | 2009-01-08 |
| HIV replication inhibiting pyrimidines and triazines Grant 7,442,705 - Guillemont , et al. October 28, 2 | 2008-10-28 |
| Hiv inhibiting 1,2,4-triazines App 20070037811 - Lewi; Paulus Joannes ; et al. | 2007-02-15 |
| Pyrimidine derivatives for the prevention of hiv infection App 20070021449 - Heeres; Jan ; et al. | 2007-01-25 |
| Hiv replication inhibiting purine derivatives App 20060293330 - Janssen; Paul Adriaan Jan ; et al. | 2006-12-28 |
| HIV inhibiting pyrimidines derivatives App 20060252764 - Guillemont; Jerome Emile Georges ; et al. | 2006-11-09 |
| HIV inhibiting pyrimidines derivatives Grant 7,125,879 - Guillemont , et al. October 24, 2 | 2006-10-24 |
| Hiv replication inhibiting pyrimidines and triazines App 20060194804 - Guillemont; Jerome Emile Georges ; et al. | 2006-08-31 |
| Hiv replication inhibiting pyrimidines and triazines App 20060142571 - Guillemont; Jerome Emile Georges ; et al. | 2006-06-29 |
| Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) App 20050004125 - Freyne, Eddy Jean Edgard ; et al. | 2005-01-06 |
| Hiv inhibiting pyrimidines derivatives App 20040198739 - Guillemont, Jerome Emile Georges ; et al. | 2004-10-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 